Survey Stroke Units in Argentina

March 10, 2025 updated by: Gerardo Candoni, Hospital de Rehabilitacion Manuel Rocca

Survey on Predictors of Discharge from Stroke Units in Argentina

Introduction Patients who receive care from stroke units are more likely to survive their stroke, become independent, and return home. Decision-making to decide the location of discharge is influenced more by non-clinical factors than clinical ones.

Objective To analyze the factors that are considered for discharge and how stroke patients are measured in stroke units in Argentina by the physicians who make the decisions.

Materials and methods An observational, analytical, cross-sectional survey-type study will be carried out. The recommendations given by the Checklist for Reporting of Survey Studies will be used. It will be intended for all those physicians in Argentina who work in stroke units and discharge.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Argentina
    • Buenos Aires
      • Caba, Buenos Aires, Argentina, 1079
        • Clinica La Sagrada Familia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Neurology/Clinical physician/Neurosurgery/Physiatrist/Other

Description

Inclusion Criteria:

  • All physicians who in stroke units of Argentina and are in charge of the referral process for hospitalized patients will be included.

Exclusion Criteria:

  • All surveys with missing data will be excluded

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Referral location
Time Frame: 3 months
It will be qualified as a polytomous qualitative variable (Rehabilitation center/Day hospital/Home/Outpatient clinic/Other)
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospital de Rehabilitacion Manuel Rocca

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2024

Primary Completion (Actual)

February 1, 2025

Study Completion (Actual)

March 2, 2025

Study Registration Dates

First Submitted

September 30, 2024

First Submitted That Met QC Criteria

September 30, 2024

First Posted (Actual)

October 2, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 10, 2025

Last Verified

June 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 12751

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe